116 related articles for article (PubMed ID: 24806321)
1. Tissue factor and tissue factor pathway inhibitor in women with a past history of preeclampsia: implication for a hypercoagulable state postpregnancy.
Lwaleed BA; Breish MO; Birch BR; Chowdhary AP; Saad RA; Perigo O; Kazmi RS; Dusse LM; Cooper AJ
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):671-4. PubMed ID: 24806321
[TBL] [Abstract][Full Text] [Related]
2. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor.
Godoi LC; Gomes KB; Alpoim PN; Carvalho Md; Lwaleed BA; Sant'Ana Dusse LM
J Thromb Thrombolysis; 2012 Jul; 34(1):1-6. PubMed ID: 22461171
[TBL] [Abstract][Full Text] [Related]
3. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
Teng Y; Jiang R; Lin Q; Ding C; Ye Z
Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor dependent pathway and the diagnosis of pre-eclampsia.
Lwaleed BA; Dusse L; Cooper AJ
Semin Thromb Hemost; 2011 Mar; 37(2):125-30. PubMed ID: 21370212
[TBL] [Abstract][Full Text] [Related]
6. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery.
Xiong Y; Zhou SF; Zhou R; Yang D; Xu ZF; Lou YT; Guo QS; Hu R; Peng T; Ma D; Li XT
Hypertens Pregnancy; 2011; 30(3):347-58. PubMed ID: 21174589
[TBL] [Abstract][Full Text] [Related]
7. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
[TBL] [Abstract][Full Text] [Related]
8. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
9. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.
Erez O; Romero R; Vaisbuch E; Than NG; Kusanovic JP; Mazaki-Tovi S; Gotsch F; Mittal P; Dong Z; Chaiworapongsa T; Kim CJ; Nhan-Chang CL; Kim SK; Yeo L; Mazor M; Hassan SS
J Matern Fetal Neonatal Med; 2018 Jun; 31(12):1568-1577. PubMed ID: 28521572
[TBL] [Abstract][Full Text] [Related]
11. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
13. The role of tissue factor in normal pregnancy and in the development of preeclampsia: A review.
Prochazkova J; Slavik L; Ulehlova J; Prochazka M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):192-6. PubMed ID: 25559093
[TBL] [Abstract][Full Text] [Related]
14. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
[TBL] [Abstract][Full Text] [Related]
16. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor and its natural inhibitor in pre-eclampsia and SGA.
Erez O; Romero R; Hoppensteadt D; Than NG; Fareed J; Mazaki-Tovi S; Espinoza J; Chaiworapongsa T; Kim SS; Yoon BH; Hassan SS; Gotsch F; Friel L; Vaisbuch E; Kusanovic JP
J Matern Fetal Neonatal Med; 2008 Dec; 21(12):855-69. PubMed ID: 19065458
[TBL] [Abstract][Full Text] [Related]
18. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.
Amengual O; Atsumi T; Khamashta MA; Hughes GR
Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy.
Ittel A; Bretelle F; Gris JC; Chau C; Sébahoun G; Boubli L; Arnoux D
Thromb Haemost; 2011 Jan; 105(1):66-71. PubMed ID: 20978710
[TBL] [Abstract][Full Text] [Related]
20. Plasma factor VII: a potential marker of pre-eclampsia.
Dusse LM; Carvalho MG; Cooper AJ; Lwaleed BA
Thromb Res; 2011 Jan; 127(1):e15-9. PubMed ID: 21094984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
